Arcus Biosciences Inc (RCUS)

EBITDA Margin

-358.12%

TTM · Period ending:

RCUS logo

RCUS EBITDA Margin

Latest reported-358.12%
RCUS TTM EBITDA Margin (-3597.31% → -358.12%)
High-resolution chart · PNG

RCUS ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Arcus Biosciences Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-358.1197%
-139.8305%
-127.5304%
-134.5833%
-107.6336%
-267.3759%
-104.2636%
-97.7186%
-95.1417%
-91.1392%
-248.7179%
-231.89%
-226.6529%
-223.731%
-229.6968%
21.1323%
18.9224%
16.9217%
15.7861%
-723.916%
-209.3664%
-192.2737%
-154.1494%
-110.531%
-739.24%
-631.5%
-567.54%
-1,189.0341%
-746.3381%
-638.3373%
-612.8936%
-637.1844%
-1,596.3966%
-2,122.3808%
-3,597.3107%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.